BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 3040163)

  • 1. The plasma kinetics of sulbactam-ampicillin administered to calves by the intramuscular and subcutaneous routes.
    Grimshaw WT; Colman PJ
    Br Vet J; 1987; 143(4):361-8. PubMed ID: 3040163
    [No Abstract]   [Full Text] [Related]  

  • 2. The parenteral kinetics of ampicillin/sulbactam in man.
    Foulds G; Knirsch AK; Stankewich JP; Weidler DR
    Int J Clin Pharmacol Res; 1985; 5(2):79-86. PubMed ID: 2991150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ampicillin/sulbactam (Unasyn).
    Med Lett Drugs Ther; 1987 Aug; 29(747):79-81. PubMed ID: 3039328
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacokinetics of sulbactam and ampicillin following oral administration of sultamicillin with probenecid.
    Emmerson AM; Cox DA; Lees LJ
    Eur J Clin Microbiol; 1983 Aug; 2(4):340-4. PubMed ID: 6313357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concentration of sulbactam and ampicillin in serum and the myometrium.
    Schwiersch U; Lang N; Wildfeuer DA
    Drugs; 1986; 31 Suppl 2():26-8. PubMed ID: 3013570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enzyme-mediated resistance to beta-lactam antibiotics: a symposium on sulbactam/ampicillin. Cairo, Egypt, April 18-19, 1985.
    Rev Infect Dis; 1986; 8 Suppl 5():S465-650. PubMed ID: 3025995
    [No Abstract]   [Full Text] [Related]  

  • 7. Stability of sulbactam/ampicillin in diluents for parenteral administration.
    Mushinsky RF; Reynolds ML; Nicholson CA; Crider LL; Forcier GA
    Rev Infect Dis; 1986; 8 Suppl 5():S523-7. PubMed ID: 3026000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative pharmacokinetics and tissue penetration of sulbactam and ampicillin after concurrent intravenous administration.
    Brown RM; Wise R; Andrews JM; Hancox J
    Antimicrob Agents Chemother; 1982 Apr; 21(4):565-7. PubMed ID: 6282211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biliary pharmacokinetics of sulbactam plus ampicillin in humans.
    Morris DL; Ubhi CS; Robertson CS; Brammer KW
    Rev Infect Dis; 1986; 8 Suppl 5():S589-92. PubMed ID: 3026008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibacterial activity of ampicillin alone and in combination with sulbactam correlated with beta-lactamase production.
    Chao HP; Ho SW; Luh KT; Hsieh WC
    Taiwan Yi Xue Hui Za Zhi; 1987 Mar; 86(3):241-7. PubMed ID: 3037003
    [No Abstract]   [Full Text] [Related]  

  • 11. [Examination of pharmacokinetics and intestinal flora following 15 days of sultamicillin or ampicillin administration].
    Okada K; Kawamura N; Ikeda M; Ueno K; Yokota T; Nishiura T
    Kansenshogaku Zasshi; 1985 Jul; 59(7):749-65. PubMed ID: 2997343
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy of sulbactam-ampicillin in an induced Pasteurella haemolytica pneumonia model in calves.
    Farrington DO; Jackson JA; Bentley OE; Barnes HJ
    Am J Vet Res; 1987 Dec; 48(12):1684-8. PubMed ID: 3434913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Ampicillin, pivampicillin and amoxycillin. Comparative studies on serum concentrations and urinary excretion after oral administration to fasting subjects].
    Knothe H; Lauer B; Fabricius K
    Arzneimittelforschung; 1974 Jun; 24(6):951-5. PubMed ID: 4368052
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacokinetics of sultamicillin in mice, rats, and dogs.
    English AR; Girard D; Haskell SL
    Antimicrob Agents Chemother; 1984 May; 25(5):599-602. PubMed ID: 6329091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of an ampicillin-sulbactam combination after intravenous and intramuscular administration to neonatal calves.
    Fernández-Varón E; Escudero-Pastor E; Cárceles-Rodríguez CM
    Vet J; 2005 May; 169(3):437-43. PubMed ID: 15848786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The elimination of sulbactam alone and combined with ampicillin in patients with renal dysfunction.
    Wright N; Wise R
    J Antimicrob Chemother; 1983 Jun; 11(6):583-7. PubMed ID: 6309731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic study of sulbactam and ampicillin administered concomitantly by intraarterial or intravenous infusion in the newborn.
    Sutton AM; Turner TL; Cockburn F; McAllister TA
    Rev Infect Dis; 1986; 8 Suppl 5():S518-22. PubMed ID: 3025999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative evaluation of the in vitro activity of three combinations of beta-lactams with beta-lactamase inhibitors: piperacillin/tazobactam, ticarcillin/clavulanic acid and ampicillin/sulbactam.
    Sader HS; Tosin I; Sejas L; Miranda E
    Braz J Infect Dis; 2000 Feb; 4(1):22-8. PubMed ID: 10788842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and bioavailability of sultamicillin estimated by high performance liquid chromatography.
    ROgers HJ; Bradbrook ID; Morrison PJ; Spector RG; Cox DA; Lees LJ
    J Antimicrob Chemother; 1983 May; 11(5):435-45. PubMed ID: 6307964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of sulbactam/ampicillin in humans: a review.
    Foulds G
    Rev Infect Dis; 1986; 8 Suppl 5():S503-11. PubMed ID: 3025997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.